Viela Bio

Viela Bio: UPLINZA® (inebilizumab, anti-CD19 mAb) on the market for the treatment of neuromyelitis optica spectrum disorder (NMOSD). Additional trials with inebilizumab ongoing, including Ph 3 trials in myasthenia gravis and IgG4-related disease. VIB7734, anti-ILT7 mAb, Ph 2 trial to initiate in 1H21. Ph 2 trials ongoing for VIB4920 (Anti-CD40L-Tn3 Fusion Protein) in Sjogren's Syndrome and kidney transplant rejection.
Based in...
US - South Atlantic
Clinical Stage
Marketed, Phase III, Phase l or ll
Disease Space
Anti-inflammatory, Autoimmune, Dermatology
Public, USA
Market Cap
1B +
One MedImmune Way
Fifth Floor, Suite Area Two
Gaithersburg, MD 20878
United States

Company Participants at Solebury Trout Virtual Management Access Event - 1x1 conference calls

  • Zhengbin Yao, PhD, CEO

Top 10 Holders of Viela Bio, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Water Island Capital LLC 0.55 301,639 15.99 Funds 2/28/21
Norges Bank Investment Management 0.43 233,832 12.40 Funds 12/31/20
AlphaSimplex Group LLC 0.04 24,543 1.30 Funds 2/28/21
The Vanguard Group, Inc. 0.04 21,106 1.12 Funds 1/31/21
Deka Investment GmbH 0.03 19,000 1.01 Funds 12/31/20
Northern Trust Investments, Inc.(Investment Management) 0.03 15,025 0.80 Funds 1/31/21
Erste Asset Management GmbH 0.02 13,400 0.71 Funds 1/29/21
American Century Investment Management, Inc. 0.01 4,483 0.24 Funds 1/31/21
Manulife Investment Management (US) LLC 0.01 3,227 0.17 Funds 2/28/21
Victory Capital Management, Inc. (Investment Management) 0.00 2,572 0.14 Funds 12/31/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.